Development of 3D-QSAR models for 5-lipoxygenase antagonists: Chalcones

Bioorganic and Medicinal Chemistry

Volumn 10, Issue 12, 2002, Pages 4035-4041

  Babu, M Arockia ^a   Shakya, Neeraj ^b   Prathipati, Philip ^b   Kaskhedikar, S G ^a   Saxena, Anil K ^b  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CHALCONE DERIVATIVE; LIPOXYGENASE INHIBITOR;

ARTICLE; BINDING SITE; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG STRUCTURE; MOLECULAR MODEL; PHARMACOPHORE; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS;

ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; BINDING SITES; CHALCONE; ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, MOLECULAR; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036978904     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00313-9     Document Type: Article

References (42)

1. (a) Young R.N. Eur. J. Med. Chem. 34:1999;671
2. (b) Kumar S., Klaus Muller K.C. Eur. J. Med. Chem. 34:1999;1035.
3. Lee D.M., Weinblatt M.E. Lancet. 358:2001;903.
4. Degreef H., Dockx P., DeDoncker P., De-Beule K., Cauwenbergh G. J. Am. Acad. Dermatol. 22:1990;751.
5. van de Kerkhof P.C., van Pelt H., Lucker G.P., Steijlen P.M., Heremans A. Skin Pharmacol. 9:1996;307.
6. Wenzel S.E. Pharmacother. 117:1997;35.
7. Hansch, C.; Sammes, P. G.; Taylor, J. B. In Comprehensive Medicinal Chemistry: Enzymes and Other Molecular Target; Pergamon: New York, 1900; Vol. 2, p 147.
8. Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., Russel R.I. N. Engl. J. Med. 20:1992;749.
9. Ford-Hutchinson, A. W. In Leukotrienes and Lipoxygenases; Rokach, J., Ed.; Elsevier: Amsterdam, 1989; p 405.
10. Ford-Hutchinson A.W. Fed. Proc. 44:1985;25.
11. Negro J.M., Miralles J.L., Funes E., Garcia A. Allergol. Immunpathol. 25:1997;209.
12. O'Byrne P.M. Chest III (Suppl.). 1997;27S.
13. Larson J.S., Jackson S.K. Am. J. Health Syst. Pharm. 53:1996;2821.
14. Sorrkness C. Pharmacotherapy. 17:1997;50. S.
15. Renzi P.M. Can. Med. Assoc. J. 160:1999;217.
16. Batt D.G., Maynard G.D., Petraitis J.J., Shaw J., Galbraith W., Harris R.R. J. Med. Chem. 33:1989;360.
17. Jones G.H., Venuti M.C., Young J.M., Murthy D.V.K., Loe B.E., Simpson R.A., Berks A.H., Kappas K.C., Beard C.C., Unger S.H., Cheung P. J. Med. Chem. 29:1986;1506.
18. Scrip No. 1306, 1988, p 28.
19. Degreef H., Dockx P., De Doncker P., De Beule K., Cauwenbergh G.A. J. Am. Acad. Dermatol. 22:1990;751.
20. Rådmark O., Malmsten C., Samuelsson B. FEBS Lett. 110:1980;213.
21. Bruneau P., Delvare C., Edwards M.P., McMillan R.M. J. Med. Chem. 34:1991;1028.
22. Bhatia P.A., Brooks C.D., Basha A., Ratajczyk J.D., Gunn B.P. J. Med. Chem. 39:1996;3938.
23. Tuchinda P., Reutrakul V., Claeson P., Pongprayoon U., Sematong T., Santisuk T., Taylor W.C. Phytochemistry. 59:2002;169.
24. Holgate S.T., Bradding P., Sampson A.P. J. Allergy Clin. Immunol. 98:1996;1.
25. (a) Summers J.B., Kim K.H., Mazdiyasni H., Holms J.H., Ratajczyk J.D., Stewart A.O., Dyer R.D., Carter G.W. J. Med. Chem. 33:1990;992
26. (b) Gupta S.P., Gupta J.K. J. Enzyme Inhib. 3:1990;179.
27. Ohkawa S., Terao Z., Shibouta V., Nishikawa K. Abstr. Quant. Struct-Act. Relat. 10:1991;392.
28. Hlasta D.J., Casey E.P., Ferrguson E.W., Gangell S.J., Heimann M.R., Jaeger E.P., Kullning R.K., Gordon R.J. Abstr. Quant. Struct-Act. Relat. 10:1991;349.
29. (a) Fleishcer R., Frohberg P., Buge A., Nuhn P. Abstr. Quant. Struct-Act. Relat. 19:2000;326.
30. Kim K.H., Martin Y.C., Brooks D.W., Dyer R.D., Carter G.W. J. Pharm. Sci. 83:1994;433.
31. Insight II, version 2.3.0; Bio Sym Technologies: San Diego, 1993.
32. Dinur, U.; Hagler, A. T. In Review of Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; Indiana University/Purdue University at Indianapolis, 1991; Vol. 2, p 99.
33. Powell M.J.D. Math. Program. 12:1977;241.
34. Dauber-Osguthorpe P., Roberts V.A., Osguthrope D.J., Wolff J., Genest M., Hagler A.T. Proteins. Struct. Funct. Genet. 4:1998;31.
35. Trupti P., Suresh K.P., Meena T., Chaturvedi S.C., Saxena A.K. Bioorg. Med. Chem. 9:2001;291.
36. Ghose A.K., Crippen G.M. J. Chem. Inf. Comput. Sci. 27:1987;21.
37. Viswanathan V.N., Ghose A.K., Revankar G.R., Robin R.K. J. Chem. Inf. Comput. Sci. 29:1989;163.
38. (a) Stewert J.J.P. QCPE Bull. 1990;455
39. (b) APEX-3D User Guide, version 1.4, 2-2, 1993.
40. Golender, V. E.; Vorpogel, E. R. In Computer Assisted Pharmacophore Identification. 3D-QSAR in Drug Design. Theory, Methods and Applications; H. Kubinyi, Ed.; ESCOM Science: 1993; p 137.
41. Golender, V. E.; Rosenblit, A. B. In Logical and Combinatorial Algorithms in Drug Design; Research Studies: Letchworth, UK, 1983.
42. Sogawa S., Yasunori N., Hiroki U., Akihiro I., Tokutaro M., Hitoshi M., Toshio S. J. Med. Chem. 36:1993;3904.